PROTECT
PROTECT - Pentoxifylline to improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis.
Principal Investigator (Rotunda site): Prof Afif El-Khuffash
The aim of PROTECT is to investigate whether intravenous pentoxyfylline (PTX) versus placebo increase survival without disability at 24 months of age in infants born at less than 29 weeks gestation with late onset sepsis or necrotising enterocolitis.